RNAC Cartesian Therapeutics, Inc.

NASDAQ

$7.41

Cartesian Therapeutics, Inc. (RNAC) Earnings News

Earnings press releases, previews and reviews for Cartesian Therapeutics, Inc. (RNAC), newest first.

Thursday August 6, 2026 7:00 AM ET

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Thursday April 30, 2026 7:00 AM ET

Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update